SS
BJDX icon

SBI Securities’s Bluejay Diagnostics BJDX Stock Holding History

SBI Securities’s Portfolio BJDX Stock Details BJDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5
Closed -$75 – 4150
2025
Q1 		$75 Buy
+5
New +$77 ﹤0.01% 3536

Other funds holding BJDX

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SBI Securities's BJDX Position: Q2 2025 in Review

SBI Securities sold out of Bluejay Diagnostics (BJDX) in Q2 2025, closing a stake of 5 shares — an estimated $75 sold.

SBI Securities first reported a position in BJDX in Q1 2025 and held it in 1 quarter. The position peaked at $75 in Q1 2025. 5 funds tracked by Wall St. Rank hold BJDX as of Q2 2025.

  • SBI Securities reported no remaining Bluejay Diagnostics position as of Q2 2025 after selling out during the quarter.
  • SBI Securities sold 5 Bluejay Diagnostics shares in Q2 2025, an estimated $75.
  • SBI Securities first reported a position in Bluejay Diagnostics in Q1 2025 and held it in 1 quarter.
  • SBI Securities's Bluejay Diagnostics position peaked at $75 in Q1 2025.
  • 5 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q2 2025.

Based on SBI Securities's 13F filing for Q2 2025, filed 8 Aug 2025.